Ellsworth P - Search Results

1

Pregnancy in sickle cell trait: what we do and don't know.

Wilson S, Ellsworth P, Key NS. Wilson S, et al. Among authors: ellsworth p. Br J Haematol. 2020 Aug;190(3):328-335. doi: 10.1111/bjh.16518. Epub 2020 Feb 17. Br J Haematol. 2020. PMID: 32064587 Free PMC article. Review.

2

Red blood cells modulate structure and dynamics of venous clot formation in sickle cell disease.

Faes C, Ilich A, Sotiaux A, Sparkenbaugh EM, Henderson MW, Buczek L, Beckman JD, Ellsworth P, Noubouossie DF, Bhoopat L, Piegore M, Renoux C, Bergmeier W, Park Y, Ataga KI, Cooley B, Wolberg AS, Key NS, Pawlinski R. Faes C, et al. Among authors: ellsworth p. Blood. 2019 Jun 6;133(23):2529-2541. doi: 10.1182/blood.2019000424. Epub 2019 Apr 5. Blood. 2019. PMID: 30952675 Free PMC article.

3

Red blood cell microvesicles activate the contact system, leading to factor IX activation via 2 independent pathways.

Noubouossie DF, Henderson MW, Mooberry M, Ilich A, Ellsworth P, Piegore M, Skinner SC, Pawlinski R, Welsby I, Renné T, Hoffman M, Monroe DM, Key NS. Noubouossie DF, et al. Among authors: ellsworth p. Blood. 2020 Mar 5;135(10):755-765. doi: 10.1182/blood.2019001643. Blood. 2020. PMID: 31971571 Free PMC article.

4

Development and application of global assays of hyper- and hypofibrinolysis.

Ilich A, Noubouossie DF, Henderson M, Ellsworth P, Betbadal KF, Campello E, Meeks S, Dunn A, Park MS, Pawlinski R, Simioni P, Shapiro A, Key NS. Ilich A, et al. Among authors: ellsworth p. Res Pract Thromb Haemost. 2019 Nov 6;4(1):46-53. doi: 10.1002/rth2.12275. eCollection 2020 Jan. Res Pract Thromb Haemost. 2019. PMID: 31989084 Free PMC article.

5

High molecular weight kininogen contributes to early mortality and kidney dysfunction in a mouse model of sickle cell disease.

Sparkenbaugh EM, Kasztan M, Henderson MW, Ellsworth P, Davis PR, Wilson KJ, Reeves B, Key NS, Strickland S, McCrae K, Pollock DM, Pawlinski R. Sparkenbaugh EM, et al. Among authors: ellsworth p. J Thromb Haemost. 2020 Sep;18(9):2329-2340. doi: 10.1111/jth.14972. Epub 2020 Aug 27. J Thromb Haemost. 2020. PMID: 32573897 Free PMC article.

6

Recombinant porcine factor VIII use in bleed treatment in non-severe haemophilia A inhibitor patients: Dosing strategies and efficacy.

Ellsworth P, Chen SL, Key N, Abajas Y, Ma A. Ellsworth P, et al. Haemophilia. 2021 Jan;27(1):e147-e150. doi: 10.1111/hae.14111. Epub 2020 Aug 25. Haemophilia. 2021. PMID: 32842162 No abstract available.

7

Recombinant porcine FVIII for bleed treatment in acquired hemophilia A: findings from a single-center, 18-patient cohort.

Ellsworth P, Chen SL, Kasthuri RS, Key NS, Mooberry MJ, Ma AD. Ellsworth P, et al. Blood Adv. 2020 Dec 22;4(24):6240-6249. doi: 10.1182/bloodadvances.2020002977. Blood Adv. 2020. PMID: 33351122 Free PMC article.

8

Sevuparin trial for acute pain in sickle cell disease: the dog that did not bark.

Ellsworth P, Little JA. Ellsworth P, et al. Lancet Haematol. 2021 May;8(5):e307-e309. doi: 10.1016/S2352-3026(21)00100-9. Lancet Haematol. 2021. PMID: 33894164 No abstract available.

9

Emicizumab reduces re-hospitalization for bleeding in acquired haemophilia A.

Chen SL, Ellsworth P, Kasthuri RS, Moll S, Ma AD, Key NS. Chen SL, et al. Among authors: ellsworth p. Haemophilia. 2021 Jul;27(4):e585-e588. doi: 10.1111/hae.14335. Epub 2021 May 29. Haemophilia. 2021. PMID: 34050698 No abstract available.

10

Emicizumab promotes factor Xa generation on endothelial cells.

Fager AM, Ellsworth P, Key NS, Monroe DM, Hoffman M. Fager AM, et al. Among authors: ellsworth p. J Thromb Haemost. 2024 Mar 8:S1538-7836(24)00121-1. doi: 10.1016/j.jtha.2024.02.017. Online ahead of print. J Thromb Haemost. 2024. PMID: 38460838

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

200 results

Search Page